CB2 receptors might serve as potential therapeutic targets for cerebral ischemia A new research published in the March issue of The American Journal of Pathology shows that cortical type 2 cannabinoid receptors might serve as potential therapeutic targets for cerebral ischemia. Researchers found that the cannabinoid trans-caryophyllene protected human brain cells from the effects of ischemia in both in vivo and in vitro animal models sildenafil effectiveness . In rats, post-ischemic treatment with TC reduced cerebral infarct edema and size.
new ed treatment
Second Quarter of Fiscal 2013 Highlights Revenues for the next quarter of fiscal 2013 elevated by 30.5 percent to RMB128.5 million from RMB98.4 million in the last year period. New subscriber sign-ups and accumulated subscriber bottom had been 18,491 and 274,705, respectively. Gross profit improved by 32.3 percent to RMB101.4 million from RMB76.7 million in the prior year period. Gross margin was 78.9 percent, compared to 77.9 percent in the last year period. Operating income improved by 24.7 percent to RMB47.0 million from RMB37.7 million in the prior year period, after taking into account the increased staff and management related costs. Interest expenditure amounted to RMB14.1 million , that was largely due to the convertible note issued to KKR China Healthcare Investment Limited , compared to RMB1.2 million in the prior year period.